Pioglitazione and bariatric surgery best for NASH treatment: Study

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2021-01-04 15:22 GMT | Update On 2021-01-05 06:03 GMT

Italy: Weight loss and hepatic insulin improvement are promising approaches for the treatment of Non‐Alcoholic Steato‐Hepatitis (NASH), suggests a recent meta-analysis in the journal Diabetes, Obesity and Metabolism. According to the study, anti-diabetic drug pioglitazione and bariatric surgery are the most effective therapies for NASH treatment.

Geltrude Mingrone, Università Cattolica del Sacro Cuore Rome, Italy, and colleagues aimed to compare different therapies for NASH and determine an effectiveness hierarchy.

The meta-analysis included randomized controlled trials or prospective trials with at least 6 months follow‐up and histologically‐proven NASH in adult participants. They performed Monte Carlo simulations, each generating 10,000 data points. The results were reported as medians and 95% Credibility Intervals (CrIs). To find the effects of BMI decrement or reduction of HOMA‐IR on NAFLD Activity Score (NAS) change, a meta‐regression was also conducted.

A total of 48 eligible trials consisting of 2356 adults (55.6% men) were included.

Key findings of the study include:

· The most effective treatments in terms of NAS reduction per semester were Pioglitazone and Roux‐en‐Y Gastric‐ByPass (RYGB) (‐1.50; 95% CrI: ‐2.08, ‐1.00 for Pioglitazione and ‐1.00; 95% CrI: ‐1.70, ‐0.32 for RYGB).

· Pioglitazone was also the best therapy for steatosis and lobular inflammation reduction; RYGB was the best treatment for hepatocellular ballooning reduction, whereas antioxidants appeared to be best for fibrosis improvement.

· For each 1% decrement in BMI, NAS was reduced by 1.3%.

· Conversely, 1% reduction of HOMA‐IR index reduced NAS by 0.3% (β=0.31%).

· Treatments that were regarded as promising, such as Elafibranor, Simtuzumab, Selonsertib, Cenicriviroc, Obeticholic acid and Liraglutide did not reduce either NAS or liver fibrosis significantly.

"Antioxidants may be effective in reducing liver fibrosis. Weight loss and improvement of hepatic insulin resistance are promising approaches in the treatment of NASH," wrote the authors.

"Pioglitazone and bariatric surgery are the most effective treatments for non‐alcoholic steato‐hepatitis: a hierarchical network meta‐analysis," is published in the journal Diabetes, Obesity and Metabolism.

DOI: https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.14304

Article Source : Diabetes, Obesity and Metabolism

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Medha Baranwal

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Pioglitazione and bariatric surgery best for NASH treatment: Study

Similar News

Semaglutide and Tirzepatide May Lower Dementia, Stroke, and Death Risk in Diabetic Patients With Obesity: Study

High Insulin Levels may Triple Risk of Abnormal Uterine Bleeding in Premenopausal Women: Study

Most Knee Deformities from Healed Rickets Self-Correct in Children Under 8, Study Finds

CTI Linked to Higher Mortality in People with Both Heart Disease and Type 2 Diabetes: Study

Medical Bulletin 18/Jul/2025

JAPI Releases Dedicated Supplement Addressing Clinical Needs for Adult Vaccination in India

Greater body roundness index among diabetes patients associated with Increased stroke risk: Study

Stress Hyperglycemia Ratio Identified as Predictor of Early Mortality in Acute CV Disease: Study